SUPPRESSOR OF CYTOKINE SIGNALING 3;
INSULIN;
SOCS3 PROTEIN, HUMAN;
SUPPRESSOR OF CYTOKINE SIGNALING;
UNCLASSIFIED DRUG;
ADULT;
ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
DISEASE PREDISPOSITION;
FEMALE;
GENETIC RISK;
GENETIC VARIABILITY;
HAPLOTYPE MAP;
HOMOZYGOSITY;
HUMAN;
INSULIN RELEASE;
INSULIN SENSITIVITY;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NUCLEIC ACID BASE SUBSTITUTION;
RISK ASSESSMENT;
SINGLE NUCLEOTIDE POLYMORPHISM;
SYSTEMATIC REVIEW;
BODY MASS;
CASE CONTROL STUDY;
GENETIC PREDISPOSITION;
GENETICS;
GENOTYPE;
METABOLISM;
PHENOTYPE;
BODY MASS INDEX;
CASE-CONTROL STUDIES;
DIABETES MELLITUS, TYPE 2;
GENETIC PREDISPOSITION TO DISEASE;
GENETIC VARIATION;
GENOTYPE;
HUMANS;
INSULIN;
PHENOTYPE;
POLYMORPHISM, SINGLE NUCLEOTIDE;
SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;
Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients
Rieusset J, Bouzakri K, Chevillotte E, Ricard N, Jacquet D, et al. (2004) Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes 53: 2232-2241.
Regulation of pancreatic beta-cell mass and proliferation by SOCS-3
Lindberg K, Ronn SG, Tornehave D, Richter H, Hansen JA, et al. (2005) Regulation of pancreatic beta-cell mass and proliferation by SOCS-3. J Mol Endocrinol 35: 231-243.
Fischer A, Fisher E, Mohlig M, Schulze M, Hoffmann K, et al. (2007) KCNJ11 E23K affects diabetes risk and is associated with the Disposition index: results of two independent German cohorts. Diabetes Care.
Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity
Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295-301.
Accurate assessment of beta-cell function: The hyperbolic correction
Bergman RN, Ader M, Huecking K, Van Citters G (2002) Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 51 Suppl 1: S212-220.
Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition
Boeing H, Korfmann A, Bergmann MM (1999) Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 43: 205-215.
diabetes in the prospective, population-based EPIC-Potsdam cohort. Diabetologia
Schulze MB, Al-Hasani H, Boeing H, Fisher E, Doring F, et al. (2007) Variation in the HHEX-IDE gene region predisposes to type 2 diabetes in the prospective, population-based EPIC-Potsdam cohort. Diabetologia.
